AFFF cancer lawsuit

AFFF Foam Remediations May Take A Coordinated Federal Response

Eliminating PFAS forever chemicals caused by AFFF firefighting foam is too great for the states and municipalities alone

Tuesday, March 19, 2024 - The persistent presence and widespread contamination of Per- and Polyfluoroalkyl Substances (PFAS) in the environment represent a significant and complex challenge to public health and environmental stewardship according to a recent article in Nature.com These substances, due to their strong carbon-fluorine bonds, resist degradation, earning them the nickname "forever chemicals." PFAS contamination has been recognized as a transboundary issue, affecting ecosystems globally from industrial sites to remote regions like Antarctica and Tibet. The pervasive nature of these chemicals, found in rainwater and tap water across the United States and beyond, underscores the urgency of a coordinated response, the publication wrote. The Environmental Protection Agency (EPA) of the United States has proposed strict restrictions to limit the levels of specific PFAS in drinking water, in response to mounting evidence of the harmful health consequences of PFAS. Although this measure is a critical step in protecting public health, it also emphasizes the greater need for all-encompassing policies to combat PFAS contamination. Water treatment facilities face a great deal of difficulty in eliminating PFAS due to the inadequacy of conventional techniques of treatment. To improve the removal of PFAS, Feng Xiao and co-authors propose integrating multi-barrier treatment trains in drinking water treatment plants. These suggestions emphasize that to effectively combat PFAS pollution, legislative actions, and technology developments must be combined. AFFF lawsuits seek to hold the manufacturers of AFFF firefighting foam to account.

AFFF attorneys believe the diversity of PFAS compounds and their widespread use across various industries further complicates the cleanup challenge. The transition away from long-chain PFAS, facilitated by voluntary agreements between the EPA and major chemical manufacturers, has led to the development of alternative PFAS compounds. However, the health and environmental impacts of these newer compounds remain largely unknown, highlighting a critical area for ongoing research and regulation. The National Center for Environmental Health (NCEH) and the Agency for Toxic Substances and Disease Registry (ATSDR) have developed a comprehensive research framework to address the multifaceted challenges posed by PFAS. This framework encompasses toxicology, exposure, human health effects, public health action, and cross-cutting priorities, aiming to provide a structured approach to understanding and mitigating PFAS exposure. By identifying priority research topics and facilitating collaboration among experts in various fields, NCEH/ATSDR aims to advance the science of PFAS and inform effective public health interventions. One cannot stress how important government cooperation is in solving the PFAS problem. A coordinated effort including numerous federal agencies, state and municipal governments, international organizations, and the private sector is crucial given the transboundary nature of PFAS pollution. Through the creation of safer substitutes for items containing PFAS, this cooperative strategy should concentrate on both preventing future pollution and alleviating current contamination. Lastly, community involvement and public education are essential components of the response to PFAS pollution. It is essential to educate communities about the dangers of PFAS exposure and the actions they may take to lessen it. This entails open communication of the results of PFAS research, the possible health effects, and the ongoing cleanup initiatives.

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.